SEC Form 4 · accession 0001315406-17-000014
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Goetz
Officer — EVP, Chief Operating Officer
Period of report
Aug 10, 2017
Accepted (ET)
Aug 11, 2017 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common StockF1 | Aug 10, 2017 | M | 2,600 | $107.32 | A | 63,811 | D | |
| Bio-Rad A Common Stock | Aug 10, 2017 | F | 1,978 | $215.00 | D | 61,833 | D | |
| Bio-Rad A Common Stock | Aug 10, 2017 | M | 1,920 | $117.00 | A | 63,753 | D | |
| Bio-Rad A Common Stock | Aug 10, 2017 | F | 1,502 | $215.00 | D | 62,251 | D | |
| Bio-Rad A Common Stock | Aug 10, 2017 | M | 2,400 | $119.54 | A | 64,651 | D | |
| Bio-Rad A Common Stock | Aug 10, 2017 | F | 1,891 | $215.00 | D | 62,760 | D | |
| Bio-Rad A Common Stock | Aug 10, 2017 | M | 1,600 | $139.56 | A | 64,360 | D | |
| Bio-Rad A Common Stock | Aug 10, 2017 | F | 1,332 | $215.00 | D | 63,028 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $107.32 | Aug 10, 2017 | M | 2,600 | D | — | Sep 12, 2022 | Bio-Rad A Common Stock | 2,600 | 650 | D |
| Non-Qualified Stock Option (right to buy)F3 | $117.00 | Aug 10, 2017 | M | 1,920 | D | — | Sep 11, 2023 | Bio-Rad A Common Stock | 1,920 | 1,280 | D |
| Non-Qualified Stock Option (right to buy)F4 | $119.54 | Aug 10, 2017 | M | 2,400 | D | — | Sep 10, 2024 | Bio-Rad A Common Stock | 2,400 | 3,600 | D |
| Non-Qualified Stock Option (right to buy)F5 | $139.56 | Aug 10, 2017 | M | 1,600 | D | — | Sep 11, 2025 | Bio-Rad A Common Stock | 1,600 | 6,400 | D |
Explanation of responses
- F1Includes 37.1639 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2017.
- F2The option vested in five equal annual installments beginning on September 12, 2013.
- F3The option vested in five equal annual installments beginning on September 11, 2014.
- F4The option vested in five equal annual installments beginning on September 10, 2015.
- F5The option vested in five equal annual installments beginning on September 11, 2016.